Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 2
2002 1
2003 1
2005 1
2006 2
2009 1
2010 2
2011 1
2012 2
2014 1
2015 2
2016 2
2019 1
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD4.
Myers SM, Miller DC, Molyneux L, Arasta M, Bawn RH, Blackburn TJ, Cook SJ, Edwards N, Endicott JA, Golding BT, Griffin RJ, Hammonds T, Hardcastle IR, Harnor SJ, Heptinstall AB, Lochhead PA, Martin MP, Martin NC, Newell DR, Owen PJ, Pang LC, Reuillon T, Rigoreau LJM, Thomas HD, Tucker JA, Wang LZ, Wong AC, Noble MEM, Wedge SR, Cano C. Myers SM, et al. Among authors: lochhead pa. Eur J Med Chem. 2019 Sep 15;178:530-543. doi: 10.1016/j.ejmech.2019.05.057. Epub 2019 May 25. Eur J Med Chem. 2019. PMID: 31212132
ERK5 and its role in tumour development.
Lochhead PA, Gilley R, Cook SJ. Lochhead PA, et al. Biochem Soc Trans. 2012 Feb;40(1):251-6. doi: 10.1042/BST20110663. Biochem Soc Trans. 2012. PMID: 22260700 Review.
Activating ROCK1 somatic mutations in human cancer.
Lochhead PA, Wickman G, Mezna M, Olson MF. Lochhead PA, et al. Oncogene. 2010 Apr 29;29(17):2591-8. doi: 10.1038/onc.2010.3. Epub 2010 Feb 8. Oncogene. 2010. PMID: 20140017
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page